Organization
University of Bonn
1 clinical trial
3 abstracts
Abstract
BIOLUMA: A phase II trial of nivolumab and ipilimumab in lung cancer—Results from the SCLC TMBhigh cohort.Org: University of Bonn, University of Frankfurt, University of Würzburg, MVZ für Hämatologie und Onkologie Köln Am Sachsenring GmbH, Hospital Cologne-Merheim,
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy of Methotrexate as Remission Maintenance Therapy After Remission-Induction Therapy With Tocilizumab and Glucocorticoids in Subjects With Giant Cell ArteritisStatus: Active (not recruiting), Estimated PCD: 2025-11-01
Abstract
INTRAMET: Results of a prospective, single-arm, open-label phase II trial of intraoperative radiotherapy after resection of brain metastases.Org: University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University Hospital, Heidelberg, Germany, University Hospital Bonn, University of Bonn,
Abstract
BORTEM-17: A phase IB/II single arm, multicentre study investigating the efficacy of sequential bortezomib and temozolomide in recurrent GBM with unmethylated MGMT promoter—The results of an interim analysis.Org: Haukeland University Hospital, Department of Oncology and Haematology, Division of Oncology, University Hospital of Modena, Modena, Italy, Bergen, Norway, Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway, Oslo University Hospital, Division of Cancer Medicine, Oslo, Norway,